Safety and Efficacy of Mitapivat Sulfate in Adult Patients With Erythrocyte Membranopathies
Phase 2
Not yet recruiting
- Conditions
- Hereditary Red Blood Cell Disorder (Disorder)
- Interventions
- First Posted Date
- 2023-07-07
- Last Posted Date
- 2023-12-26
- Lead Sponsor
- EuroBloodNet Association
- Target Recruit Count
- 25
- Registration Number
- NCT05935202
- Locations
- 🇳🇱
Department of Internal Medicine, University Medical Center Utrecht, Utrecht, Netherlands
🇩🇰Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
© Copyright 2025. All Rights Reserved by MedPath